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  ABSTRACT 
The present work deals with the preparation of ceramic composites that can be employed for the 
development of load bearing bone implants in total knee and hip replacement. Zirconia (ZrO2) is 
a bio-inert, strong, and resistant ceramic, while titania (TiO2) is bioactive but is believed to have 
poor mechanical properties. It is expected that yttria stabilized ZrO2-TiO2 ceramic composites 
incorporate the desirable properties of both ceramics, so that this composite would exhibit better 
in-vivo biological properties. The composites of Ti-ZrO2 (0.2 mass fraction) stabilised with 3 
mol% yttria with different particle size were prepared using powder metallurgy. The obtained 
powders were then sintered at 1300 °C for 1 hr in normal atmosphere subsequent to dry pressing 
at 130MPa. Sintering led to the oxidation of titanium into titanium oxide(titania).Phase 
characterization was analyzed by XRD, morphological features were assessed by SEM, hardness 
was measured by micro-hardness tester and MTT assay was used for the measurement of cell 
viability in vitro to understand the compatibility of implant in body environment.  
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1.1 INTRODUCTION 
The modern day medicine is in a transition from curing damaged/diseased organs of the patient 
by hectic and time consuming surgical operations to replacing the damaged/diseased organ 
completely with in vitro synthesized implants. Hard tissue and bone replacements are 
synthesized mainly from materials having similar chemical, mechanical properties and phase 
structure to those of the hard tissues. Study on the synthesis of new biomaterials involves the use 
of the existing biomaterials with a new composite material with improved properties, 
modification of the microstructure of the present biomaterials and chemical synthesis to form a 
new novel biomaterial. Metals such as stainless steel and titanium alloy and ceramics such as 
alumina, and zirconia are common in a variety of implant materials. However, these materials 
are considerably stiffer than human bone. The elasticity or modulus mismatch between an 
implant material and the host tissue can cause bone to yield at the implant-bone interface, which 
leads to implant instability and subsequent failure [1]. A durable bone replacement requires the 
establishment of a stable bone-implant interface, which requires the careful matching of the 
mechanical behaviour as well as physico-chemical properties of synthetic implant materials with 
the natural tissue [2]. Material researchers are currently working on the development of 
biocompatible materials which can mimic the properties of natural bone. Molecularly designed 
composite materials that mimic the structure and properties of bone offer the best solution to the 
problems of interfacial stability and stress shielding of load-bearing prostheses. 
                                    As compared to metals, ceramics often cause reduced osteolysis and are 
regarded as favorable materials for joints or joint surface materials. Titanium and its alloys are 
the most biocompatible because of their resistance and tolerance to body fluids. It has high 
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fatigue strength, low weight, & outstanding corrosion resistance. However they posses poor 
shear strength and wear resistance. Titania (TiO2) is a ceramic material, which is generally used 
as a coating material in the femoral head in hip prosthesis. Fine grained TiO2 particles with a 
narrow size distribution are desirable for producing advanced ceramics with enhanced reliability 
[3]. Recently, TiO2 fine-grained particles have become a topic of extensive biological and 
physico-chemical investigations. TiO2 surface layers have been coated on metal substrates and 
have shown extraordinary biocompatibility. The titania coating has shown promising bioactivity; 
& has the ability to form chemical bonding with bone in the body. Despite its poor mechanical 
properties, and being inferior to hydroxyapatite in terms of bone apposition rate and bone 
bonding strength, titania is relatively stable in a biological environment and is able to provide 
long-term bone bonding. TiO2 ceramics are promising for implant applications. Zirconia has high 
thermal stability, high bending strength, high fracture toughness, high ionic conductivity, good 
wear resistance. Zirconia can be stabilised with various additives such as CaO, Y2O3,MgO etc 
among which yttria and cerium are the most effective stabilisers. In particular, yttria-stabilised 
zirconia (ZrO2), is known to be both hard and tough at room temperature because its addition 
reduces the temperature of tetragonal to monoclinic transformation of zirconia polymorph. 
Zirconia ceramics have an advantage over alumina ceramics i.e. they have higher toughness & 
higher flexural strength & lower youngs modulus. 
1.2 OBJECTIVE 
The objective of this present study is the preparation of TiO2 and Yttria stabilized ZrO2 (3Y-PSZ) 
composite and to find out their potential application in load bearing implants. In this present 
work the following specific objectives has to be achieved:- 
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(i) Selection of appropriate concentration of Ti and Yttria stabilized zirconia for preparing the 
composite by ball milling. 
(ii) Transformation of Titanium to Titania followed by the formation of Titania-Yttria-zirconia 
composite by sintering at oxidizing atmosphere and to find out the correlation between the 
microstructure before and after sintering. 
(iii) Phase analysis of the samples will be carried out by XRD study before and after sintering to 
find out any abnormal change. 
(iv) The micro hardness test will be carried out to evaluate the hardness of the composite. 
(v) Assessment of cell viability of the composite material will be performed by MTT assay.   
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2.1 BIOMATERIALS 
A biomaterial is a nonviable material used in medical device, intended to interact with biological 
system[4].The most requisite property of all the biomaterials is biocompatibility or non-toxicity 
which is the definition of a material that is not recognized by the body as a potentially harmful 
foreign substance and does not produce potentially toxic products in the body environment. Once 
an implant is placed inside the body, an injury response is initiated by the tissue that results in 
inflammation as a reaction to any local injury. Not all biocompatible materials are inert in the 
body but the highly bioactive ones incorporate to the actions of body like providing a host matrix 
for tissue growth or being slowly replaced by the growing tissue on or near its surface. 
Biocompatible materials can classified as bioinert, resorbable and bioactive according to tissue 
response. Formation of a fibrous tissue of variable thickness is induced in bioinert materials, 
bond at the interfaces is developed on bioactive materials, and resorbable materials are replaced 
by the surrounding tissue [4]. Mechanical property correlation of the biomaterial to the host or 
replaced tissue is another important property. Especially in hard tissue replacements in load 
bearing implants the biomaterial is required to support or share a portion of the load. Wear 
resistance, Compressive strength, fracture toughness and hardness of biomaterials are important 
in these cases. The list of biomaterials used in body implants with their properties has been 
enumerated in Table 2.1[5]. 
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Table. 2.1 list of biomaterials used in body implants with their properties 
Type                                          Properties      Applications 
Polymers 
PMMA   High toughness, stability   Bone cement 
Excellent light transmittance   Intraocular lenses 
 
PHEMA   Excellent light transmittance   Soft contact lenses 
Polyacrylic acid  High adhesive strength   Dental cement 
Mucosal drug 
delivery 
Polyethylene   High toughness, wear resistance  Catheters 
Acetabular cups in 
artificial hips 
Polypropylene   High tensile strength, chemical  Sutures 
Resistance     Hernia repair 
 
                                                        
PTFE    High hydrophobicity    Catheters 
     Excellent lubricity    Vascular grafts 
 
Poly(dimethyl siloxane) Low Tg     Finger joints 
     Low mechanical properties   Heart valves 
High flexibility    Breast implants 
 
PET    High tensile strength    Arterial grafts 
           Fixation of implants 
Polyurethane   High fatigue resistance   Pacemaker insulation 
Vascular grafts 
 
Metals 
316L Stainless steel               High corrosion resistance   Bone screws 
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High strength     Hip prostheses 
 
Co-Cr-Mo F75  High corrosion resistance   Heart valve stents 
     Low fatigue resistance 
Ti-6Al-4V   High strength     Heart housing 
     High corrosion resistance   Heart valve stents 
 
Ceramics 
Al2O3    High corrosion resistance   Hip prostheses 
High wear resistance    Dental implants 
 
ZrO2    Low modulus of elasticity   Articulating ball in 
High strength     total hip prosthesis 
Hydroxyapatite  High bioactivity    Dental implants 
Low strength     Alveolar ridge 
Periodontal pocket 
 
Calcium phosphates  High bioactivity    Degradable bone filler 
Pyrolytic carbon  High Strength     Heart valves 
High wear resistance    Dental implants 
                                        
Composites 
Hydroxyapatite-  High bioactivity    Bone implant 
Polyethylene   High toughness 
Alumina-Zirconia  High wear resistance    Femoral heads 
 
Natural Materials 
Chitosans         Wound dressing 
Collagen         Soft tissue coatings 
Gelatin         Artificial heart  
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2.2 BIOCERAMICS 
Ceramics are a versatile group of materials that are abundant in type. Oxides are the most 
commonly used ceramics also found in great quantities in nature. The chemical synthesis, 
fabrication and heat treatment processes of oxides are relatively easier and simpler compared to 
other materials. The desired characteristic properties common to all ceramics are chemical 
stability, low density, high hardness, low tensile strength and high compressive strength. 
Ceramics are ideal materials for mobile load bearing components in aggressive environments 
such as those in automobile engine blocks, refractories and hard tissue replacements. Following 
contact with body tissue, exposed surface of a biomaterial is covered rapidly with proteins that 
are adsorbed from the surrounding body fluids. The nature of the adherent protein layer is 
controlled by the substrate chemistry, due to its effect on wettability and surface charge. 
Although cells are able to adhere, spread and grow on bare biomaterial surfaces in vitro, proteins 
adsorbed from the adjacent tissue environment and adherent cells enhance cell attachment, 
migration and growth. The chemical nature of a biomaterial placed in the body as an implant 
therefore is important in functioning of the body. Some ceramics that have been tested in vivo do 
not cause increased activity of immune system when dissolved in body fluid or in contact with  
body tissues. Such ceramics, mainly oxides, are termed as bioceramics. Bioceramics have the 
advantage of being compatible with the human body environment. Due to their excellent 
tribological properties and with their improved fracture toughness and reliability, structural 
ceramics such as polycrystalline alumina and toughened zirconia have been used as hard tissue 
replacement materials. One remarkable success of bioceramics as implant materials over the last 
two decades has been the emergence and clinical use of bioactive ceramics that elicit a specific 
biological response at the interface of the material resulting in the formation of a strong bond 
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between the tissue and the material. These bioceramics include calcium phosphates with 
hydroxyapatite, Bioglasss, A-W glass–ceramic, and other bioactive glasses and glass–ceramics 
[6]. However, the brittle nature of ceramics such as alumina and the low strength of bioactive 
ceramics such as hydroxyapatite have limited their scope of clinical applications. Bioceramics 
can be classified into four groups based on their type of attachment to the surrounding tissues. 
Dense and nearly inert ceramics get attached to the bone by morphological fixation, or growth of 
bone into surface irregularities. Porous and inert ceramics are attached to the bone by on-growth 
of the tissue or biological fixation. Dense and surface reactive ceramics attach directly by 
chemical bonding to the bone or via bioactive fixation. Resorbable ceramics get attached to the 
bone by any of the above mechanisms and are slowly replaced by bone.  
2.3 COMPOSITE: 
Composites are derived materials obtained by combining advantageous properties of 
metallic/ceramic/polymeric materials to achieve property which is higher than sum total of 
individual phase characteristics. Three distinct composite classes- Metal-Metal Composite, 
Polymer-Metal Composite and Ceramic-Metal Composite. It is essential that each component of 
the composite be biocompatible to avoid degradation between interfaces of the constituents. It 
has been known that interfaces in these material systems, especially composites play a critical 
role in observed mechanical properties much like the role of load transfer mechanisms at HAP–
collagen interfaces in real bone [7]. 
2.4. TITANIA AND YTTRIA STABILISED ZIRCONIA: 
Pure titania is subject to anatase to rutile phase transformation, although the transformation 
temperature varies. It was reported that the anatase to rutile phase transformation could be 
reduced by a small amount of zirconia, which was present in the form of solid solution with the 
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host titania [8]. With zirconia as the dopant, anatase phase with high crystallinity and high phase 
stability was maintained even after annealing at 1000
0
C for 1 h [9].It has been observed that 
TiO2 particles fuse together with increasing sintering temperature,and all of the sintered TiO2 
membranes are porous.In addition the TiO2 membranes obtained in air are seen to be more 
compact than that obtained in argon at same temperature.[10]. It has been found that the grain 
boundary diffusion is faster by about 5 orders of magnitude than the bulk diffusion of titanium in 
yttria satbilised zirconia.[11]. 
 Zirconia is an inert ceramic in its pure form which possesses extraordinary properties when 
doped with certain stabilizing oxides such as yttria, magnesia and calcia. It is a well-known 
polymorph that occurs in three forms: monoclinic (M), tetragonal (T), and cubic (C). Pure 
zirconia is monoclinic at room temperature. This phase is stable up to 1170°C. Above this 
temperature it transforms into tetragonal and then into cubic phase at 2370°C. During cooling, a 
T to M transformation takes place in a temperature range of about 100°C below 1070°C. The 
improved mechanical property due to transformation toughening of tetragonal zirconia is utilized 
in biocomposites as well as conventional ceramic to have a better mechanical property. 
Obtaining stable sintered zirconia ceramic products is difficult because of the large volume 
change accompanying the transition from tetragonal to monoclinic (about 9%). Stabilization of 
the tetragonal polymorph of zirconia over wider range of temperatures is accomplished by 
substitution of some of the Zr
4+
 ions (ionic radius of 0.82 Å, too small for ideal lattice of 
fluorite  characteristic for the tetragonal zirconia) in the crystal lattice with slightly larger ions, 
e.g., those of Y
3+
 (ionic radius of 0.96 Å). The resulting doped zirconia materials are 
termed stablized zirconias.[12]  
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Fig 2.1: Yttria stabilized zirconia crystal lattice representation[12] 
The addition of yttria to pure zirconia replaces some of the Zr
4+
 ions in the zirconia lattice with 
Y
3+
 ions. This produces oxygen vacancies, as three O
2-
 ions replace four O
2-
 ions. It also permits 
yttrium stabilized zirconia to conduct O
2-
 ions (and thus conduct an electrical current), provided 
there is sufficient vacancy site mobility, a property that increases with temperature. This ability 
to conduct O
2-
 ions makes yttria-stabilized zirconia well suited to use in solid oxide fuel cells, 
although it requires that they operate at high enough temperatures. The ionic conductivity of the 
stabilized zirconias increases with increasing dopant concentration (linearly for low dopant 
concentrations), then saturates, and then starts to decrease. The properties of interest to the 
engineer utilizing zirconia ceramics include strength, toughness, hardness, wear resistance and 
thermal properties.. The yttria content is the most significant controlling variable in yttria 
stabilized zirconia ceramics. In order to improve the mechanical properties it is essential to have 
a microstructure free of any monoclinic phase which would act as a flaw, and this dictates the 
minimum level of stabiliser added. Approximately 1.8 mol% yttria in solid solution results in a 
ceramic with a composition close to the phase boundary where the metastable tetragonal phase is 
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transformable. As a consequence high values of fracture toughness can be obtained with this 
composition. A maximum in the fracture strength is obtained at the 3 mol % yttria composition 
in research done so far. Tetragonal zirconia experiences a degradation when in contact with 
water at temperatures in the 200-300 °C range due to ageing of the metastable phase which 
restricts its use in long term applications [13].Biomedical grade zirconia exhibits the best 
mechanical properties of oxide ceramics. The mechanical properties of commercial yttria 
stabilized zirconia is given in Table 2.2[14]. 
 Table 2.2:  Mechanical properties of commercial yttria stabilized zirconia. 
 
 
 
 
 
 
 
A Synthetic bone substitute should have similar strength to that of the cortical/cancellous bone 
being replaced (>200MPa). It should also have a similar modulus of elasticity to that of bone 
(20GPa) in an attempt to prevent both stress shielding and fatigue fracture under cyclic loading 
by maintaining adequate toughness [15]. 
 
Mechanical properties of zirconia TZ-3Y 
Density 6.05 g/cm3 
Hardness   1200 HV 
Bend strength  900-1200 MPa 
Compressive 
strength 
  2000 MPa 
Fracture toughness 7-10 MPa/m1/2 
Young’s modulus     210 GPa 
21 
 
 
 
 
 
 
 
 
 
 
                                                                        
                                                                       CHAPTER 3 
MATERIALS AND METHODS 
EXPERIMENTAL PROCEDURE  
CHARACTERISATION TECHNIQUES  
HARDNESS TEST 
BIOCOMPATIBILTY TEST 
22 
 
3.1 EXPERIMENTAL PROCEDURE 
Commercial powders of titanium, zirconia and yttria and were used in synthesis of mechanically 
mixed composite samples. The samples were weighed in the electronic balance according to the 
following calculation:- 
Mole% of Y2O3=3% 
Mass fraction of zirconia=20% w/w 
Total mass of composite to be prepared=5g 
Molar mass of ytrria = 225.81g/mol 
Molar mass of zirconia = 123.21g/mol 
Thus, mass of zirconia = 5*0.02g =1g 
Mass of yttria used = 0.03*225.81[mass of zirconia/123.21 + mass of yttria/225.81] 
                            = 0.05g 
Mass of titanium = (5-1-0.05)g = 3.95g. 
3.1.1 BALL MILLING:- 
The weighed samples were then ball milled in a SPEX 8000 mixer mill in inert gas atmosphere 
for 150 min and 300 min. The vial and the balls used in the milling procedure were made up of 
stainless steel. The ball to powder ratio was 10:1. 
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3.1.2 BINDER SOLUTION PREPARTION:-  
4 %(w/v) PVA ( Poly Vinyl Alchol) binder solution was prepared by 0.25 gm of PVA in 20 mL 
of distilled water. It was heated on a magnetic stirrer, simultaneously stirred. The weighed 
amount of PVA (0.25 gm) was added in small proportions, only when the previous addition had 
dissolved. It was ensured that the temperature remained below 90°C. Usually, constant heating is 
not required and it was heated in intervals but continuously stirred. Sometimes extra water was 
also added to keep up the required percentage of water. Continuous stirring resulted in a clear 
transparent solution. This binder was uniformly mixed with the ball milled sample in a mortar 
and kept to dry. 
3.1.3 COMPACTION AND SINTERING: 
After complete drying the hardened mass was finely ground.The dry ground powder was the 
measured to make the pellets. Green pellets of 7 mm diameter and 3 mm height were made by 
die pressing under a load of 2 tonnes (130 Mpa) with a dwell time of 20 sec. The pelletized 
samples were sintered at 1300 °C for 1 hr in normal atmosphere at 3
0
C/min rise in temperature. 
This led to the oxidation of titanium to titanium oxide. 
3.2 CHARACTERISATION TECHNIQUES: 
3.2.1 SCANNING ELECTRON MICROSCOPE: 
A scanning electron microscopy (SEM) is used for the check the surface morphology of the 
sample. In this type of electron microscope, images of the sample are scanned with the help 
electrons. The electrons interact with the atoms that generate the sample producing signals that 
contain information about the sample's surface composition, topography etc. At a potential of 15 
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KV, samples were scanned at different magnifications and images produced were used for 
further analysis. 
3.2.2 X-RAY DIFFRACTION ANALYSIS 
The composition of the titania-3Y PSZ composite samples was analyzed using X-Ray 
diffraction. Samples were studied in a X’PERT PANalytical X-Ray diffractometer with a 
graphite monochromator. X-Ray intensity was measured for angles in the range 20°<2Ɵ °<80° 
with scan rate of 3° per minute and time pulse of 1
0
/min. The diffraction patterns produced were 
then compared with the existing data using JCPDS data file. To identify the phases present, the 
location of peaks in the XRD profiles were compared to reference spectra. 
3.3 HARDNESS TEST: 
The hardness measurement of the sintered composites was carried out with Vickers hardness 
tester. The model of the instrument used for finding out the Vickers hardness was LM248AT. 
Hardness of all the samples were measured under 300 gm loads. 
3.4 BIOCOMPATIBILTY TEST (MTT ASSAY): 
The cytotoxicity study was carried out for titania 3Y-PSZ sample with ball milling time for 150 
and 300 min by direct contact method. MNCs from passage 4 were used for this study.The MTT 
assay has been performed following protocol given by Mosmann et al [16]. In brief, a cell 
suspension containing 5 × 10
4 
cells was incubated in 96 well plates to get uniform monolayer.  
Then, sterilized composites were kept on the surface of monolayer in direct contact and 
incubated at 37
0
C under 5% CO2 for 24 hr. After incubation for 24 hr, composites were taken out 
from wells and media was removed. 10 µl of MTT solution (5 mg/ml) was added to respective 
well incubated at 37
0
C for 4 hr. DMSO of 100 µl was used to solubilise formazan and 
absorbance was measured at 595 nm in a micro plate reader(Perkin Elmer 2030 explorer).  
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4.1. Morphological characterization 
Figure 4.1 shows the scanning electron micrograph of the compacted titanium-3Y-PSZ 
composite after ball milling for two different time duration at different magnifications. Fig 4.1 
(a) represents the ball milled titanium-3Y-PSZ composite for 150 mins at 500X magnification 
which shows fine grained particles forming agglomerates having nearly circular grain boundaries 
of non-uniform size while in case of fig 4.1(b) which represents ball milled titanium-3Y-PSZ 
composite for 300 mins at 500X magnification, the particle size is smaller compared to the 
earlier one. Cracks at the interfaces are also visible Further under higher magnification, in fig 
4(c) the structure becomes more visible and uniform grain distribution with globular grain 
boundaries on the surface is visualised. Cracks can also be located at the interfaces. In fig 4(d) 
for the 300 min titanium-3Y-PSZ composite, the particle size has decreased significantly with 
slightly uniform grain size. The grains are globular with hexagonal boundaries. This indicates 
that with increase in ball mill duration the average particle size decreases and more 
agglomeration is formed among the particles.    
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Figure 4.1: Scanning electron micrograph of compacted titanium-3Y-PSZ composite after ball 
milling for (a) 150 min at 500X (b) 300 min at 500 X (c) 150 min at 5,000X (d) 300 min at 
5,000X 
 
Figure 4.2 shows the scanning electron micrograph of the compacted titania-3Y-PSZ composite 
after sintering at 1300
O 
C for 1h at different magnifications. Fig 4.2(a) represents the 150 min 
titania-3Y-PSZ composite having nearly uniform grain size with some cracks at the grain 
interfaces while for the 300 min titania-3Y-PSZ composite in fig 4.2(b) the grains are more 
a b 
c d 
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compact and uniformly distributed. In fig 4.2(c) the sintered titania-3Y-PSZ composite of 150 
min depict the formation of circular agglomerates which are more or less uniformly distributed. 
The particle size of this sample was calculated with the help of ImageJ software for 30 grains 
and the average grain size was found to be 23micrometers. In fig 4.2(d) the sintered titania-3Y-
PSZ composite of 300 min exhibit more pore formation and non uniform grain size distribution 
having globular geometry. In this case the average grain size was calculated to be about 19.2 
micrometers. Upon further magnifying the 150 min titania-3Y-PSZ composite in fig 4.2 (e) we 
observe that the grains are attached to each other at the interfaces which reveals that the grain 
boundary interaction between titania and zirconia composite are good enough. Fig 4.2(f) 
representing 300 min titania-3Y-PSZ composite also indicates the effective agglomeration at 
grain interface with hexagonal grain boundary.  
 
a b 
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Figure 4.2: Scanning electron micrograph of the compacted titanium-3Y-PSZ composite after 
sintering at 1300
O 
C for 1h. (a) 150 min at 100X (b) 300 min at 100 X (c) 150 min at 500X (d) 
300 min at 500X (e) 150 min at 6,000X (f) 300 min at 6,000 X 
 
 
 
 
c d 
e f 
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4.2. Phase identification: 
 
Figure 4.3 X-ray differaction plot of compacted titanium-3Y-PSZ composite after ball milling 
for 150 min. 
The phase change before and after sintering was measured with XRD to study the monoclinic to 
tetragonal and titanium to titania phase change. Obtained peaks were matched with JCPDS data 
card no. 77-0442 (TiO2), 27-0997 (ZrO2), 76-0151 (Y2O3), 44-1294(Ti). The XRD patterns of 
compacted titanium-3Y-PSZ composite after ball milling for 150 min are represented in Fig. 4.3. 
The XRD patterns display the presence of titanium as the predominant phase along with a small 
amount of zirconia and yttria peaks. However, after the transformation of titanium into titania via 
sintering at 1300
O 
C for 1h, the intensity of the titania (TiO2) increases with a concurrent increase 
in ZrO2,Y2O3 peaks as in fig 4.4 . It can be deduced from fig 4.4 (b) more populated uniformly 
distributed peaks are obtained in case of the 300 min titania-3Y-PSZ.The presence of TiO2 peaks 
confirm the oxidation of Ti into TiO2 after sintering. 
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`    
                                                        (a) 
 
                                                     (b) 
Figure 4.4 X-ray differaction plot of of the compacted titania-3Y-PSZ composite after sintering 
at 1300
O 
C for 1h after ball milling for (a) 150 min and (b) 300 min 
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4.3  Hardness test: 
 Table 4.3.1 Micro hardness value for sintered titania-yttria stabilized zirconia composite 
for 150 mins: 
 
LOAD APPLIED(gm) 
 
VICKER’S 
MICROHARDNESS(HV) 
 
300 
 
816.4 
 
300 
 
591.6 
 
300 
 
697.1 
 
300 
 
743.2 
 
300 
 
660.2 
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 Table 4.3.2.Micro hardness value for sintered titania-yttria stabilized zirconia composite 
for 300 mins: 
 
LOAD APPLIED(gm) 
 
VICKER’S 
MICROHARDNESS(HV) 
 
300 
 
765.6 
 
300 
 
601.8 
 
300 
 
940.1 
 
300 
 
804.7 
 
300 
 
733.8 
                 
From the above tabulations of table 4.5.1 and 4.5.2 the average hardness values were calculated 
to be 769.2 HV and 701.7 HV for 300 min and 150 min sintered titania-3Y-PSZ. This illustrates 
that the sample having less particle size are more tough and are resistant to external load. This 
makes them potentially favourable for load bearing applications.  
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4.4 Biocompatibility study (MTT assay study) – 
Fig 4.6.1 shows the biocompatibility study of sintered 300 min titania 3Y-PSZ sample. This 
reveals that the sample is biocompatible with better cell reproducibility on its surface.  
 
 
Fig.4.6.1 MTT assay test for cell toxicity and reproducibility for 300 min titania 3Y-PSZ  
sintered sample 
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.  
Fig.4.6.2 MTT assay test for cell toxicity and reproducibility for 150 min titania 3Y-PSZ  
sintered sample.  
The relationship between cell number and the amount of formazan generated was tested by 
measuring the intensity of absorbance. The absorbance was directly proportional to the number 
of cells in the culture medium (in approx.). From the Figure 4.6.1 it has been observed that the 
readings of the test samples are in good agreement with those of the control sample which shows 
there is rise in number of viable cells which represents the nontoxic and biocompatibility nature 
of titania 3Y-PSZ composite sample. The 300 min sample is likely to have a better cell growth as 
compared to that of the 150 min titania-3Y-PSZ composite. 
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5.1 CONCLUSIONS 
Synthesis of titania-yttria stabilized zirconia composite has been achieved following techniques 
like powder metallurgy, ball milling and subsequent sintering. The optimum concentrations of 
samples were determined[17]. The titania-yttria stabilized zirconia composite powders have been 
examined for optimization of particle size, particle morphology and phase analysis. The SEM 
studies reveal that the grain agglomerate with each other are quite well and is better in the 300 
min ball milled composite. Hardness values are also impressive in order to withstand substantial 
amount of load. The phase analysis confirmed the presence of titania after conversion via 
sintering in normal atmosphere. The biocompatibility test revealed that the samples are 
biocompatible and do not for toxic compounds in the body environment and hence can be used 
as a reliable option in load bearing implants. 
 
5.2 FUTURE WORK 
It can be proposed that in the future research can be carried out in order to compare the results of 
metal-ceramic i.e titanium-3YPSZ and ceramic-ceramic titania-3YPSZ composite for application 
in load bearing implants. Characterisation techniques such as wear resistance and corrosion 
resistance can also be carried out. 
 
 
 
 
38 
 
5.3 REFERNCES 
[1]  J.B.Park, Biomaterials: an Introduction, Plenum Press, New York, (1979)  
[2]  W.Bonfield, Metals and Materials, Vol.3, (1987), 712-716. 
[3] H.K. Park, D.K. Kim, C.H. Kim, Effect of solvent on titania particle formation and 
morphology in thermal hydrolysis of TiCl4, J. Am.Ceram. Soc. 80 (3) (1997) 743–749. 
[4] Ratner, B.D., Hoffman, A.S., Schoen, F.J., Lemons, J.E., 2004 “Biomaterials Science,An 
Introduction to Materials in Medicine, 2nd edition”, (Elsevier Academic Press, San Diego) 
pp.162  
[5] Erdem Sahin, Graduate School of Engineering and Sciences of Izmir Institute of Technology, 
September 2006,Page 4. 
[6] Wang, M., 2003 “Developing Bioactive Composite Materials for Tissue Replacement”, 
Biomaterials, Volume 24, Issue 13, pp. 2133-2151 
[7] Kalpana S. katti, ”Biomaterials in total joint replacement” Colloids and Surfaces B: 
Biointerfaces 39 (2004) 133–142 
[8] J. Yang, J.M.F. Ferreira, On the titania phase transition by zirconia additive in a sol–gel-
derived powder, Mater. Res. Bull. 33 (3) (1998) 389–394. 
[9] M. Hirano, C. Nakahara, K. Ota, M. Inagaki, Direct formation of zirconia-doped titania with 
stable anatase-type structure by thermal hydrolysis, J. Am. Ceram. Soc. 85 (5) (2002) 1333–
1335. 
[10] Shouyong ZHOU, Zhao xiang ZHONG, Yiqun FAN “Effects of Sintering Atmosphere on 
the Microstructure and Surface Properties of Symmetric TiO2 Membranes”, Chinese Journal of 
Chemical Engineering, Volume 17, Issue 5, October 2009, Pages 739–745.  
39 
 
[11] K.kowalski et al,”Bulk and grain boundary diffusion of titanium in yttria stabilized 
zirconia”, Journal of the European Ceramic Society,Pg 951-958. 
[12] http://en.wikipedia.org/wiki/Yttria-stabilized_zirconia. 
[13] Stevens, R., 1986 “Zirconia and Zirconia Ceramics, 2nd edition”, (Magnesium Elektron 
Ltd.). 
[14] Piconi, C., Maccauro, G., 1999 “Zirconia as a Ceramic Biomaterial”, Biomaterials, Volume 
20, Issue 1, pp. 1-25 
[15] Giannoudis, P.V., Dinopoulos, H., Tsiridis, E., 2005 “Bone Substitutes: An Update” ,Injury, 
Int. J. Care Injured, Issue 365, pp. 20-27. 
[16] Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to 
proliferation and cytotoxicity assays. J Immunol methods.1983:65:55-63. 
[17]  P Kazutoshi Katahira, Hiroshi Kotani, Jun Komotori and Hitoshi Ohmori.” Development of 
Titanium/Zirconia Composite by Spark Plasma Sintering (SPS) Method for Artificial Hip Joint” 
[18] B. Fartash, H. Liao, J. Li, N. Fouda, L. Hermansson, Long-term evaluation of titania-based 
ceramics compared with commercially pure titanium in vivo, J. Mater. Sci.: Mater. Med. 6 (8) 
(1995) 451– 454. 
[19] L. Fu, K.A. Khor, J.P. Lim, Effects of yttria-stabilized zirconia on plasma-sprayed 
hydroxyapatite/yttria-stabilized zirconia composite coatings, J. Am. Ceram. Soc. 85 (4) (2002) 
800–806. 
[20] V.J.P. Lima, K.A. Khor, L. Fu, P. Cheang, Hydroxyapatite–zirconia composite coatings via 
the plasma spraying process, J. Mater. Process. Technol. 89–90 (1999) 491–496. 
[21] J. Yang, J.M.F. Ferreira, On the titania phase transition by zirconia additive in a sol–gel-
derived powder, Mater. Res. Bull. 33 (3) (1998) 389–394. 
40 
 
[22] M. Hirano, C. Nakahara, K. Ota, M. Inagaki, Direct formation of zirconia-doped titania with 
stable anatase-type structure by thermal hydrolysis, J. Am. Ceram. Soc. 85 (5) (2002) 1333–
1335. 
[23] M. Wei, M. Uchida, H.-M. Kim, T. Kokubo, T. Nakamura, Apatite-forming ability of CaO-
containing titania, Biomaterials 23 (2002) 167–172. 
[24] M. Daturi, A. Cremona, F. Milella, G. Busca, E. Vogna, Characterisation of zirconia–titania 
powders prepared by coprecipitation, J. Eur. Ceram. Soc. 18 (8) (1998) 1079–1087. 
[25] Von Recum (Ed.), Handbook of Biomaterials Evaluation, Scientific, Technical and Clinical 
Testing of Implant Materials, second ed., Taylor and Francis, PA, 1999, p. 915. 
[26] J. Black, Biological Performance of Materials: Fundamentals of Biocompatibility, Marcel 
Deckker, New York, 1992. 
[27] M. Long, H.J. Rack, Biomaterials 19 (1998) 1621. 
[28] G.K. Mckee, J. Watson-Ferrar, J. Bone Jt. Surg. 48 (1996) 245. 
[29] P.S. Walker, B.L. Gold, Wear 17 (1971) 285. 
[30] J.A. Davidson, F.S. Georgette, State-of-the-Art Materials for orthopaedic Prosthetic 
Devices: on Implant Manufacturing and Material Technology, Proc. Soc. of Manufacturing 
Engineering, Itasca,IL. 
[31] John Brunski, in: B.D. Ratner, A.S. Hoffman, F.J. Schoen, J.E. Lemons (Eds.), Biomaterials 
Science an Introduction to Materials in Medicine, Academic Press, CA, 1996. 
[32] P. Christel, A. Meunier, A.J.C. Lee (Eds.), Biological and Biomechanical Performance of 
Biomaterials, Elsevier, Amsterdam, The Netherlands, 1997, pp. 81–86. 
 
                                                           ---------- *---------- 
41 
 
 
 
